We received a question on which costs can be covered by the VeZo ruling of the Healthcare Institute (Zorginstituut) and whether this is a useful ruling for small companies with a need for additional funding in case they need to do research to answer the question: Is the new care as effective as or more effective than the existing treatment that is already reimbursed for the patient population in question?
In recent communication (October 2024) it is stated that the ruling is on hold. Tijdspad subsidierondes | Fondsbeheer en analyse zorgkostenontwikkeling | Zorginstituut Nederland.